Current state of breast cancer surgery in Andalusia and Catalonia

Información del artículo

Abstract

Background

Surgery is an essential element of breast cancer treatment. The aim of this study was to describe the progress and current practice in oncological breast surgery in Catalonia and Andalusia.

Material and method

An observational study was conducted, collecting data from the Minimum Basic Data Set at Hospital Discharge.

Results

A total of 37 537 women from Catalonia and 24 186 from Andalusia were studied. The rate of admission due to breast cancer in women increased substantially during the study period, as well as the percentage of women who underwent breast-conserving surgery. However, the increase in breast-conserving surgery has not been consistent among age groups and hospital levels.

Conclusions

As a whole, the increase in breast-conserving surgery has shown the need for interventions to promote the use of procedures of proven effectiveness.

Keywords:

Breast cancer

Oncological surgery

Mastectomy

Trends

Catalonia

Andalusia

Resumen

Introducción

La cirugía es un elemento esencial en el tratamiento del cáncer de mama. El objetivo del trabajo es describir la evolución y el estado actual de la cirugía oncológica de mama en Cataluña y Andalucía.

Material y método

Se llevó a cabo un estudio observacional basado en el análisis del Conjunto Mínimo Básico de Datos de Altas Hospitalarias en el período 1996–2005.

Resultados

La muestra incluyó a 37.537 mujeres de Cataluña y 24.186 de Andalucía. En el periodo estudiado se produjo un notable incremento de las tasas de hospitalización. Igualmente hay un marcado incremento en el porcentaje de casos intervenidos mediante cirugía conservadora. Sin embargo, esta difusión de la cirugía conservadora ha sido desigual por grupos de edad y tipo de centro.

Conclusiones

En conjunto se pone de relieve el aumento de la proporción de mujeres tratadas con mastectomía subtotal y la necesidad de estrategias que favorezcan la diseminación de intervenciones de probada efectividad

Palabras clave:

Cáncer de mama

Cirugía oncológica

Mastectomía

Tendencias

Cataluña

Andalucía

El Texto completo está disponible en PDF

References

[1.]

P. Boyle, J. Ferlay.

Cancer incidence and mortality in Europe, 2004.

Ann Oncol, 16 (2005), pp. 481-488

http://dx.doi.org/10.1093/annonc/mdi098 | Medline

[2.]

La situación del Cáncer en España. Madrid: Área de. Epidemiología Ambiental y Cáncer. Centro Nacional de Epidemiología. Instituto de Salud Carlos III; 2005. p. 80–1.

[3.]

E. Fernández, J.R. González, J.M. Borrás, V. Moreno, V. Sánchez, M. Peris.

Recent decline in cancer mortality in Catalonia (Spain). A joinpoint regression analysis.

Eur J Cancer, 37 (2001), pp. 2222-2228

Medline

[4.]

A. Cayuela, S. Rodriguez-Dominguez, M. Ruiz-Borrego, M. Gili.

Age-period-cohort analysis of breast cancer mortality rates in Andalucía (Spain).

Ann Oncol, 15 (2004), pp. 686-688

Medline

[5.]

Mansfield CM. Early breast cancer. Its history and results of treatment. En: Experimental Biology and Medicine. Monographs on Interdisciplinary Topics. Vol. 5. New York: Karger; 1976.

[6.]

A.M. Cotlar, J.J. Dubose, D.M. Rose.

History of surgery for breast cancer: radical to the sublime.

Curr Surg, 60 (2003), pp. 329-337

http://dx.doi.org/10.1016/S0149-7944(02)00777-8 | Medline

[7.]

C.S. Bland.

The Halsted mastectomy: present illness and past history.

West J Med, 134 (1981), pp. 549-555

Medline

[8.]

E.R. Fisher, B. Fisher, R. Sass, L. Wickerham.

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol n. 4). XI. Bilateral breast cancer.

Cancer, 54 (1984), pp. 3002-3011

Medline

[9.]

S. Hellman, R. Heimann.

The clinical significance of tumor progression: breast cancer as a model.

Cancer J, 6S (2000), pp. 131-133

[10.]

W.S. Payne, W.F. Taylor, S. Khonsari, J.H. Snider, E.G. Harrison, H. Golenzer, et al.

Surgical treatment of breast cancer. Trends and factors affecting survival.

Arch Surg, 101 (1970), pp. 105-113

Medline

[11.]

B. Fisher, C. Redmond, E.R. Fisher, et al.

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

N Engl J Med, 312 (1985), pp. 674-681

http://dx.doi.org/10.1056/NEJM198503143121102 | Medline

[12.]

B. Fisher, J. Jeong, S. Anderson, et al.

Twenty-five-year follow-up of a randomized clinical trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation.

N Engl J Med, 347 (2002), pp. 567-576

http://dx.doi.org/10.1056/NEJMoa020128 | Medline

[13.]

U. Veronesi.

Rationale and indications for limited surgery in breast cancer: current data.

World J Surg, 11 (1987), pp. 493-498

Medline

[14.]

B. Fisher, N. Wolmark, E.R. Fisher, M. Deutsch.

Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations.

World J Surg, 9 (1985), pp. 692-698

Medline

[15.]

M.A. Martin, R. Meyricke, T. O’Neill, S. Roberts.

Breast-conserving surgery versus mastectomy for survival from breast cancer: the Western Australian experience.

Ann Surg Oncol, 14 (2007), pp. 157-164

http://dx.doi.org/10.1245/s10434-006-9203-9 | Medline

[16.]

Comorbilidad e índice de Charlson. Aplicaciones en CMBD. Valencia: Escola Valenciana d’Estudis de la Salut. Quaderns de Salut Pública i Administració de Serveis de Salut. 2001:18.

[17.]

Instituto Nacional de Estadística [cited Jun, 20 2007]. Available from: http://www.ine.es.

[18.]

Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modelling using Stata. College Station: Stata Press; 2005. 19. STATA (Version 9.2). Available from: http://www.stata.com.

[20.]

Descripción del Cribado del Cáncer en España. Proyecto DESCRIC [monografía en Internet]. Barcelona: AATRM; 2007 [cited May 22, 2008]. Available from: http://desarrollo-aets.isciii.es/web/guest/buscador_productos?p_p_id=ConsultaProyectos&p_p_action=1&p_p_state=maximized&_p_mode=-view&_ConsultaProyectos_struts_action=/ext/aets/verproducto&_ConsultaProyectos_codProducto=70&_ConsultaProyectos_fecha=Fri+May+.

[20.]

M. Martín, A. Llombart-Cussac, A. Lluch, E. Alba, B. Munárriz, I. Tusquets, Grupo GEICAM, et al.

Estudio epidemiológico del grupo GEICAM sobre el cáncer de mama en España (1990–1993): proyecto El Álamo.

Med Clin (Barc), 122 (2004), pp. 12-17

[22.]

U. Veronesi, B. Salvadori, A. Luini, A. Banfi, R. Zucali, M. Del Vecchio, et al.

Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Ann Surg, 211 (1990), pp. 250-259

Medline

[23.]

B. Fisher, C. Redmond, R. Poisson, R. Margolese, N. Wolmark, L. Wickerham, et al.

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

N Engl J Med, 320 (1989), pp. 822-828

http://dx.doi.org/10.1056/NEJM198903303201302 | Medline

[24.]

B. Fisher, J. Bryant, N. Wolmark, E. Mamounas, A. Brown, E.R. Fisher, et al.

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

J Clin Oncol, 16 (1998), pp. 2672-2685

http://dx.doi.org/10.1200/jco.1998.16.8.2672 | Medline

[25.]

E.P. Mamounas.

NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel.

Oncology, 11 (1997), pp. 37-40

Medline